In July 2021, an evaluation of Organisation for Economic Cooperation and Development (OECD) 443 studies led by the European Chemicals Agency (ECHA) revealed critical issues with study designs that had the potential to compromise data analysis and interpretation. This webinar will summarize the regulatory recommendations and the subsequent impact of these recommendations upon study design, resources, time and cost.